Shirley Girshengorn

Evaluation of a Benchtop HIV Ultradeep Pyrosequencing Drug Resistance Assay in the Clinical Laboratory

Boaz Avidor, Shirley Girshengorn, Natalia Matus et al. · Journal of Clinical Microbiology · 2013 · 37 citations · Full text

Life Sciences, Pharmacology, Clinical Pharmacology +16

Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018

Tali Wagner, Neta S. Zuckerman, Tami Halperin et al. · Viruses · 2021 · 27 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +17

A Population-Structured HIV Epidemic in Israel: Roles of Risk and Ethnicity

Zehava Grossman, Boaz Avidor, Zohar Mor et al. · PLoS ONE · 2015 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +17

Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel

Eugene Katchman, Ronen Ben‐Ami, M. Savyon et al. · Clinical Microbiology and Infection · 2016 · 17 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +10

Comparison between Roche and Xpert in HIV-1 RNA quantitation: A high concordance between the two techniques except for a CRF02_AG subtype variant with high viral load titters detected by Roche but undetected by Xpert

Boaz Avidor, Natalia Matus, Shirley Girshengorn et al. · Journal of Clinical Virology · 2017 · 15 citations

Life Sciences, Infectious Diseases, Molecular Biology +14